Poster-OCU400
Loading viewer...
report
Format: PDF report
This report details the Phase 1/2 clinical trial of OCU400, a potential gene therapy for Retinitis Pigmentosa and Leber Congenital Amaurosis, highlighting its safety and efficacy.
Loading viewer...
report
Format: PDF report
This report details the Phase 1/2 clinical trial of OCU400, a potential gene therapy for Retinitis Pigmentosa and Leber Congenital Amaurosis, highlighting its safety and efficacy.
presentation
report
Altiris
report
Deutsche Bank
report
Carlyle Group
report
PineBridge Investments
